NCT06003829View on ClinicalTrials.gov

A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

September 20, 2023

Study Completion Date

September 20, 2023

Conditions
Healthy
Interventions
DRUG

Sinsunatovir

Single dose, to be spit out after tasting

OTHER

Bitrex

Single dose, to be spit out after tasting

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06003829 - A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants. | Biotech Hunter | Biotech Hunter